Voxzogo 0.4 mg

Voxzogo 0.4 mg is a medicine authorised by Swissmedic under authorisation number 69569. The authorisation holder is DRAC AG. The medicinal product code is Biotechnological medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 30 January 2025 and the authorisation is limited until 29 January 2030. ATC code M05BX07 places the medicine in the group Drugs for treatment of bone diseases.

  • Dispensing category A
  • Authorisation number 69569
  • ATC M05BX07
  • Biotechnological medicines
Authorisation data
Authorisation number69569
NameVoxzogo 0.4 mg
Full nameVoxzogo 0.4 mg, Pulver und Lösungsmittel zur Herstellung einer Injektionslösung
Authorisation holderDRAC AG
Medicinal product codeBiotechnological medicines
Dispensing categoryA · Prescription, not repeatable
ATC codeM05BX07
First authorisation30 January 2025
Authorisation validity29 January 2030
Strengths
No.NameDispensing categoryAuthorisation date
1Voxzogo 0.4 mg, Pulver und Lösungsmittel zur Herstellung einer InjektionslösungA30 January 2025
2Voxzogo 0.56 mg, Pulver und Lösungsmittel zur Herstellung einer InjektionslösungA30 January 2025
3Voxzogo 1.2 mg, Pulver und Lösungsmittel zur Herstellung einer InjektionslösungA30 January 2025

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
110StückM05BX0707.99.0.A
210StückM05BX0707.99.0.A
310StückM05BX0707.99.0.A

Scroll the table sideways

Other medicines from this authorisation holder

Frequently asked questions

Is Voxzogo 0.4 mg authorised in Switzerland?

Yes. Voxzogo 0.4 mg is authorised by Swissmedic under authorisation number 69569, data as of 01 September 2026. The authorisation is limited until 29 January 2030.

Which dispensing category does Voxzogo 0.4 mg have?

Voxzogo 0.4 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.

Who is the authorisation holder of Voxzogo 0.4 mg?

The authorisation holder is DRAC AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com